| Top Adding |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Writing and Speaking > Writing and Speaking > 188 Stage Hero's Journey (Monomyth): Shape Shifter Denied |
|
Top Adding - 188 Stage Hero's Journey (Monomyth): Shape Shifter Denied
The Hero's Journey (Monomyth) is the template upon which the vast majority of successful stories and Hollyw According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ood blockbusters are based upon. In fact, ALL of the hundreds of Hollywood movies we have deconstructed (se ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in URL below) are based on this 188+ stage template. Understanding this template is a priority for story or lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. creenwriters. This is the template you must master if you are to succeed in the craft. [The terminology is here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe most often metaphoric and applies to all successful stories and screenplays, from The Godfather (1972) to B d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro okeback Mountain (2006) to Annie Hall (1977) to Lord of the Rings (2003) to Drugstore Cowboy (1989) to Thel ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ma and Louise (1991) to Apocaplyse Now (1979)]. THERE IS ONLY ONE STORY THE HERO'S JOURNEY: a) Attempts easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi o tap into unconscious expectations the audience has regarding what a story is and how it should be told. nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ) Gives the writer more structural elements than simply three or four acts, plot points, mid point and so o and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ . c) Gives you a tangible process for building and releasing dissonance (establishing and achieving cathar ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi es, of which there are usually four). d) Gives you a universal structural template upon which you can supe ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a rimpose your situational story. This is why stories such as Alien (1979), Gladiator (2000), Midnight Cowboy dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod (1969), American Beauty (1999), The Graduate (1967) and many others (all deconstructed at the URL below) ap cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ear to be different but are all constructed, almost sequence by sequence, in the same way. and more... AB tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen IDGED TIP(S): *****Shape Shifter Denied***** Very often, it is here [post the Rebirth but before the Rewa t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel d] where the Romantic Challenge decides to reject the Shape Shifter (who is the Hero's romantic competitor) ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust , and accept the Hero. Shape Shifter Inadequacy. Here, the Shape Shifter's inadequacy - the reason he is i y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ferior to the Hero - is made explicit. Shape Shifter's Turning. It is very often here that the Shape Shift . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de r decides which way to turn - from good to bad or vice versa. This may or may not be a result of the reject elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip on. Accept the Hero. It is here that the Romantic Challenge's decision to accept the Hero is made explicit tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:You're the Expert, You Fire Him! FAQs - Licensing Intellectual Property (IP)
|